Wfs1-deficient mice display altered function of serotonergic system and increased behavioral response to antidepressants

Frontiers in Neuroscience

Volumn , Issue 7 JUL, 2013, Pages

  Visnapuu, Tanel ^a   Raud, Sirli ^a   Loomets, Maarja ^a   Reimets, Riin ^a   Sütt, Silva ^a   Luuk, Hendrik ^a   Plaas, Mario ^a   Kõks, Sulev ^a   Volke, Vallo ^a   Alttoa, Aet ^a   Harro, Jaanus ^a   Vasar, Eero ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Behavioral despair; Forced swimming test; Imipramine; Noradrenaline reuptake transporter; Paroxetine; Serotonin reuptake transporter; Tail suspension test; Wfs1 deficient mice

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; IMIPRAMINE; NORADRENALIN; PAROXETINE; PROTEIN; SEROTONIN; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG; WFS1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CATECHOLAMINERGIC SYSTEM; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FORCED SWIM TEST; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HOPELESSNESS; IMMOBILITY; MALE; MESENCEPHALON; MOTOR ACTIVITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PONS; PROTEIN EXPRESSION; SEROTONIN METABOLISM; TAIL SUSPENSION TEST; TREATMENT RESPONSE;

EID: 84898683200     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2013.00132     Document Type: Article

References (42)

1. Bai, F., Li, X., Clay, M., Lindstrom, T., and Skolnick, P. (2001). Intra- and interstrain differences in models of "behavioural despair". Pharmacol. Biochem. Behav. 70, 187-192. doi: 10.1016/S0091-3057(01)00599-8
2. Balleine, B. W., Delgado, M. R., and Hikosaka, O. (2007). The role of the dorsal striatum in reward and decision-making. J. Neurosci. 27, 8161-8165. doi: 10.1523/JNEUROSCI.1554-07.2007
3. Billings, A., and Moos, R. (1984). Coping, stress, and social resources among adults with unipolar depression. J. Pers. Soc. Psychol. 46, 877-891.
4. Bolden-Watson, C., and Richelson, E. (1993). Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci. 52, 1023-1029. doi: 10.1016/0024-3205(93)90194-8
5. Bourin, M., Chenu, F., Ripoll, N., and David, D. J. (2005). A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests. Behav. Brain Res. 164, 266-269. doi: 10.1016/j.bbr.2005.06.015
6. Carlezon, W. A. Jr., and Thomas, M. J. (2009). Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology 56, 122-132. doi: 10.1016/j.neuropharm.2008.06.075
7. David, D. J., Renard, C. E., Jolliet, P., Hascoët, M., and Bourin, M. (2003). Antidepressant-like effects in various mice strains in the forced swimming test. Psychopharmacology (Berl) 166, 373-382.
8. Drevets, W. C., Frank, E., Price, J. C., Kupfer, D. J., Holt, D., Greer, P. J., et al. (1999). PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiatry 46, 1375-1387. doi: 10.1016/S0006-3223(99)00189-4
9. Folkman, S., and Lazarus, R. S. (1988). Coping and emotion. Soc. Sci. Med. 26, 309-317.
10. Franklin, K. B. J., and Paxinos, G. (1997). The Mouse Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press.
11. Gardier, A. M. (2009). Mutant mouse models and antidepressant drug research: focus on serotonin and brain-derived neurotrophic factor. Behav. Pharmacol. 20, 18-32. doi: 10.1097/FBP.0b013e3283243fcd
12. Goddard, A. W., Ball, S. G., Martinez, J., Robinson, M. J., Yang, C. R., Russell, J. M., et al. (2010). Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depress. Anxiety 27, 339-350. doi: 10.1002/da.20642
13. Hyttel, J. (1993). Comparative pharmacology of selective serotonin reuptake inhibitors (SSRIs). Nord. J. Psychiatry 47, 5-12.
14. Ishihara, H., Takeda, S., Tamura, A., Takahashi, R., Yamaguchi, S., Takei, D., et al. (2004). Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion. Hum. Mol. Genet. 13, 1159-1170.
15. Jacobson, L. H., and Cryan, J. F. (2007). Feeling strained? Influence of genetic background on depression-related behavior in mice: a review. Behav. Genet. 37, 171-213. doi: 10.1007/s10519-006-9106-3
16. Kato, T., Ishiwata, M., Yamada, K., Kasahara, T., Kakiuchi, C., Iwamoto, K., et al. (2008). Behavioural and gene expression analyses of Wfs1 knockout mice as a possible animal model of mood disorder. Neurosci. Res. 61, 143-158. doi: 10.1016/j.neures.2008.02.002
17. Koido, K., Kõks, S., Nikopensius, T., Maron, E., Altmäe, S., Heinaste, E., et al. (2005). Polymorphisms in wolframin (WFS1) gene are possibly related to increased risk for mood disorders. Int. J. Neuropsychopharmacol. 8, 235-244. doi: 10.1017/S1461145704004791
18. Krishnan, V., and Nestler, E. J. (2008). The molecular neurobiology of depression. Nature 455, 894-902. doi: 10.1038/nature07455
19. Liu, X., and Gershenfeld, H. K. (2001). Genetic differences in the tail-suspension test and its relationship to imipramine response among 11 inbred strains of mice. Biol. Psychiatry 49, 575-581. doi: 10.1016/S0006-3223(00)01028-3
20. Luuk, H., Kõks, S., Plaas, M., Hannibal, J., Rehfeld, J. F., and Vasar, E. (2008). Distribution of Wfs1 protein in the central nervous system of the mouse and its relation to clinical symptoms of the Wolfram syndrome. J. Comp. Neurol. 509, 642-660. doi: 10.1002/cne.21777
21. Luuk, H., Plaas, M., Raud, S., Innos, J., Sutt, S., Lasner, H., et al. (2009). Wfs1-deficient mice display impaired behavioural adaptation in stressful environment. Behav. Brain Res. 198, 334-345. doi: 10.1016/j.bbr.2008.11.007
22. Malison, R. T., Price, L. H., Berman, R., van Dyck, C. H., Pelton, G. H., Carpenter, L., et al. (1998). Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol. Psychiatry 44, 1090-1098.
23. Matto, V., Terasmaa, A., Vasar, E., and Kõks, S. (2011). Impaired striatal dopamine output of homozygous Wfs1 mutant mice in response to [K+] challenge. J. Physiol. Biochem. 67, 53-60. doi: 10.1007/s13105-010-0048-0
24. Nemeroff, C. B., and Owens, M. J. (2009). The role of serotonin in the pathophysiology of depression: as important as ever. Clin. Chem. 55, 1578-1579. doi: 10.1373/clinchem.2009.123752
25. Nestler, E. J., and Carlezon, W. A. Jr. (2006). The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 59, 1151-1159. doi: 10.1016/j.biopsych.2005.09.018
26. Owens, M. J., Morgan, W. N., Plott, S. J., and Nemeroff, C. B. (1997). Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J. Pharmacol. Exp. Ther. 283, 1305-1322.
27. Patterson, T. L., Semple, S. J., Temoshok, L. R., Atkinson, J. H., McCutchan, J. A., Straits-Troster, K. A., et al. (1993). Depressive symptoms among HIV positive men: life stress, coping and social support. J. Appl. Biobehav. Res. 1, 64-87. doi: 10.1111/j.1751-9861.1993.tb00028.x
28. Porsolt, R. D., Bertin, A., and Jalfre, M. (1977). Behavioural despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229, 327-336.
29. Porsolt, R. D., Chermat, R., Lenegre, A., Avril, I., Janvier, S., and Steru, L. (1987). Use of the automated tail suspension test for the primary screening of psychotropic agents. Arch. Int. Pharmacodyn. Ther. 288, 11-30.
30. Raud, S., Sütt, S., Luuk, H., Plaas, M., Innos, J., Köks, S., et al. (2009). Relation between increased anxiety and reduced expression of alpha1 and alpha2 subunits of GABA(A) receptors in Wfs1-deficient mice. Neurosci. Lett. 460, 138-142. doi: 10.1016/j.neulet.2009.05.054
31. Razzoli, M., Carboni, L., Guidi, A., Gerrard, P., and Arban, R. (2007). Social defeat-induced contextual conditioning differentially imprints behavioral and adrenal reactivity: a time-course study in the rat. Physiol. Behav. 92, 734-740. doi: 10.1016/j.physbeh.2007.05.063
32. Richelson, E. (2001). Pharmacology of antidepressants. Mayo Clin. Proc. 76, 511-527.
33. Ripoll, N., David, D. J., Dailly, E., Hascoët, M., and Bourin, M. (2003). Antidepressant-like effects in various mice strains in the tail suspension test. Behav. Brain Res. 143, 193-200. doi: 10.1016/S0166-4328(03)00034-2
34. Salamone, J. D., Correa, M., Nunes, E. J., Randall, P. A., and Pardo, M. (2012). The behavioural pharmacology of effort-related choice behaviour: dopamine, adenosine and beyond. J. Exp. Anal. Behav. 97, 125-146. doi: 10.1901/jeab.2012.97-125
35. Shank, R. P., Vaught, J. L., Pelley, K. A., Setler, P. E., McComsey, D. F., and Maryanoff, B. E. (1988). McN-5652: a highly potent inhibitor of serotonin uptake. J. Pharmacol. Exp. Ther. 247, 1032-1038.
36. Sütt, S., Raud, S., Abramov, U., Innos, J., Luuk, H., Plaas, M., et al. (2010). Relation of exploratory behaviour to plasma corticosterone and Wfs1 gene expression in Wistar rats. J. Psychopharmacol. 24, 905-913. doi: 10.1177/0269881109102738
37. Swift, M., and Swift, R. G. (2000). Psychiatric disorders and mutations at the Wolfram syndrome locus. Biol. Psychiatry 47, 787-793. doi: 10.1016/S0006-3223(00)00244-4
38. Swift, M., and Swift, R. G. (2005). Wolframin mutations and hospitalization for psychiatric illness. Mol. Psychiatry 10, 799-803. doi: 10.1038/sj.mp.4001681
39. Swift, R. G., Polymeropoulos, M. H., Torres, R., and Swift, M. (1998). Predisposition of Wolfram syndrome heterozygouserozygotes to psychiatric illness. Mol. Psychiatry 3, 86-91.
40. Swift, R. G., Sadler, D. B., and Swift, M. (1990). Psychiatric findings in Wolfram syndrome homozygotes. Lancet 336, 667-669. doi: 10.1016/0140-6736(90)92157-D
41. Visnapuu, T., Plaas, M., Reimets, R., Raud, S., Terasmaa, A., Kõks, S., et al. (2013). Evidence for impaired function of dopaminergic system in Wfs1-deficient mice. Behav. Brain Res. 244, 90-99. doi: 10.1016/j.bbr.2013.01.046
42. Zhu, M. Y., Klimek, V., Dilley, G. E., Haycock, J. W., Stockmeier, C., Overholser, J. C., et al. (1999). Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression. Biol. Psychiatry 46, 1275-1286. doi: 10.1016/S0006-3223(99)00135-3